IGF2 and ovarian cancer: The combination of the above mentioned six biomarkers (MIF, OPN, CA125, IGF II, leptin and prolactin) has been shown to improve differentiation between disease free and ovarian cancer patients compared to CA125 alone in patients without a family history of OC [18,19].